Latest Breaking News On - Martin nicklasson - Page 4 : vimarsana.com

Basilea Pharmaceutica AG: Basilea reports strong financial results 2022 based on successful implementation of new strategy

22% year-on-year increase of royalty income from antifungal Cresemba®Operating profit of CHF 18.5 million and net profit of CHF 12.1 millionStrengthened balance sheet through non-dilutive repayment of

Basilea Pharmaceutica AG: Basilea shareholders approve all proposals of the board of directors at the annual general meeting

Press Release Basel, Switzerland, April 13, 2022 Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that shareholders approved all proposals of the board of directors at today's annual general

Investegate |Basilea Pharmaceutica AG Announcements | Basilea Pharmaceutica AG: Basilea shareholders approve all proposals of the board of directors at the annual general meeting

Investegate announcements from Basilea Pharmaceutica AG, Basilea shareholders approve all proposals of the board of directors at the annual general meeting

Notice To Attend The Annual General Meeting Of Shareholders

IRLAB Therapeutics: Notice To Attend The Annual General Meeting Of Shareholders

GOTHENBURG, SWEDEN / ACCESSWIRE / April 11, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)The shareholders of IRLAB Therapeutics AB, company registration no. 556931-4692 ("IRLAB" or the "Company")